Corvus Pharmaceuticals (CRVS) Receivables - Other (2015 - 2024)

Corvus Pharmaceuticals' Receivables - Other history runs 6 years deep, the most recent figure standing at $70000.0 for Q3 2024.

• In Q3 2024, Receivables - Other changed N/A year-over-year to $70000.0; the TTM figure through Sep 2024 stood at $70000.0 (changed N/A YoY), while the FY2023 annual figure was $26000.0, down 95.58% from the prior year.
• Receivables - Other was $70000.0 for Q3 2024 at Corvus Pharmaceuticals, up from $35000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $588000.0 in Q4 2022 to a low of $26000.0 in Q4 2023.
• Historically, Receivables - Other has averaged $291454.5 across 4 years, with a median of $373000.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other jumped 82.25% in 2022, then slumped 95.58% in 2023.
• A 4-year view of Receivables - Other shows it stood at $507000.0 in 2021, then rose by 15.98% to $588000.0 in 2022, then plunged by 95.58% to $26000.0 in 2023, then surged by 169.23% to $70000.0 in 2024.
• The last three Receivables - Other figures came in at $70000.0 (Q3 2024), $35000.0 (Q2 2024), and $26000.0 (Q1 2024), per Business Quant data.